Drug intelligence / Profile preview

Amobang

Development stage
Unknown
Lead developer
Ruiyang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Amobang is a brand name for amoxicillin capsules, a generic aminopenicillin antibiotic developed and manufactured by Ruiyang Pharmaceutical. Amoxicillin is a semi-synthetic, broad-spectrum β-lactam antibiotic that exerts its bactericidal activity by inhibiting the synthesis of bacterial cell walls. It specifically binds to and inactivates penicillin-binding proteins (PBPs), which are enzymes located on the inner membrane of the bacterial cell wall responsible for the final stages of peptidoglycan cross-linking. This disruption leads to the weakening of the cell wall and subsequent osmotic lysis and death of the bacteria. Amobang is indicated for the treatment of various infections caused by susceptible Gram-positive and Gram-negative microorganisms, including those affecting the respiratory tract, urinary tract, and skin. The product has been evaluated in bioequivalence studies, such as CTR20171004, to demonstrate its pharmacokinetic comparability to the reference listed drug, Amoxil.

Brand names
Amobang
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Amobang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amobang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call